What Are Bioidentical Hormones? UK Context Explained

A plain-English UK explainer on what “bioidentical hormones” can mean, why regulated body-identical medicines and compounded products should not be treated as the same route, and which product, prescriber, pharmacy, cost, monitoring, and follow-up checks matter.

About this entry

This is a factual terminology and route-quality explainer for UK users. It does not recommend hormone treatment, compare products or providers, assess suitability, interpret test results, or give prescribing or dosing advice.

The short answer

“Bioidentical hormones” is a broad phrase used for hormones described as chemically identical to hormones produced by the human body. In UK menopause and HRT discussions, the wording can refer either to regulated, authorised medicines or to compounded products made for an individual patient. Those routes are not interchangeable.

The British Menopause Society distinguishes regulated bioidentical HRT (rBHRT) from compounded bioidentical HRT (cBHRT). Its current consensus statement says regulated options follow the conventional medicines-authorisation route, while compounded products do not follow the same MHRA regulatory pathway. The product name, licence status, prescriber, supplying pharmacy, reason for the route, monitoring plan, total cost, and follow-up therefore matter more than the word “bioidentical” alone.

Why bioidentical and body-identical wording can be confusing

UK clinic, menopause, pharmacy, and HRT pages may use “bioidentical”, “body-identical”, “natural”, “bespoke”, “personalised”, or “compounded” as if they describe one category. They do not necessarily show the same product or regulatory route.

The British Menopause Society uses rBHRT for regulated products and cBHRT for compounded products. Other UK public-facing material may use “body-identical” to help distinguish regulated medicines from compounded bioidentical preparations. Because marketing terminology varies, users should ask for the exact medicine or preparation rather than infer product status from the adjective.

Regulated and compounded routes are different

Regulated route An identifiable medicine developed and authorised through the conventional regulatory pathway, with product information that can be checked.
Compounded route A preparation made or supplied for an individual patient that does not follow the same MHRA authorisation pathway as a conventional licensed product.
What the wording does not prove That a product is licensed, suitable, safer, more effective, more personalised, or supported by stronger evidence.
What to verify Exact product or preparation, licence status, accountable prescriber, dispensing or supplying pharmacy, clinical reason, costs, monitoring, and follow-up.

NICE advises that the efficacy and safety of unregulated hormone preparations are unknown and that the safety, quality, and purity of constituents in unregulated preparations may also be unknown. The British Menopause Society says compounded bioidentical HRT is not recommended by national or international guidance and notes that regulated options are available.

This does not mean every non-standard or unlicensed medicine route is unlawful. MHRA guidance recognises “specials” made or imported for an individual patient after an authorised prescriber orders them. It does mean that an unlicensed or specially prepared route should not be presented as if it carries the same product authorisation as a licensed medicine.

Product and route checks before paying

A stronger provider route should be able to answer basic factual questions without relying on “natural” or “bespoke” language. Ask for the exact medicine or preparation name, whether it is a licensed UK product, who makes the prescribing decision, and which registered pharmacy dispenses or supplies it.

If a compounded or unlicensed preparation is proposed, ask why a licensed alternative is not being used and how the prescriber has documented the clinical reason, consent, monitoring, and follow-up. If a clinic mentions a specialist pharmacy, the public pharmacy-register trail should match the business and contact details shown to the patient.

Testing, monitoring, and costs

The British Menopause Society says there is insufficient evidence to justify multiple serum and saliva hormone tests that are claimed to individualise compounded bioidentical HRT precisely. A claim that repeated testing makes a compounded route uniquely “bespoke” should therefore be checked carefully rather than accepted as proof of quality.

Private route costs may extend beyond the first consultation. Users should separate consultation, blood or saliva testing, prescription, preparation or medicine supply, dispensing, delivery, repeat testing, membership, review, cancellation, and follow-up charges. A higher price, a subscription, or the word “personalised” does not establish better evidence or care.

Monitoring should have a named clinical purpose and accountable reviewer. The provider should explain who reviews symptoms and results, how side effects are handled, what happens when results are abnormal, how the patient’s GP is involved where appropriate, and what happens if treatment is changed, paused, or stopped.

Questions before booking or paying

  • What is the exact name and formulation of the medicine or preparation?
  • Is it a licensed UK medicine, or is it compounded or otherwise unlicensed?
  • If it is compounded or unlicensed, why is that route being proposed instead of a licensed alternative?
  • Who assesses the patient and makes the prescribing decision, and which professional register applies?
  • Which pharmacy dispenses or supplies the product, and can its register entry be checked?
  • Which tests are used, why are they needed, and who interprets the results?
  • Which consultation, testing, prescription, product, dispensing, delivery, repeat, and review costs are included?
  • Who handles side effects, abnormal results, medicine changes, ongoing monitoring, and follow-up?

Red flags in bioidentical hormone claims

  • “Bioidentical”, “natural”, “body-identical”, or “bespoke” is presented as proof that a product is licensed, safer, or more effective.
  • The exact medicine or compounded preparation is not named before payment.
  • A personalised formula is promised mainly from repeated saliva or blood tests without a clear clinical explanation.
  • The prescriber, supplying pharmacy, legal business, or product status is difficult to identify.
  • Treatment or a particular result is promised before assessment.
  • Headline pricing does not explain testing, prescriptions, product supply, dispensing, monitoring, and repeat-review fees.
  • Side-effect support, abnormal-result handling, records, and follow-up are unclear.
Why this distinction matters

“Bioidentical” describes a claimed relationship to hormones made by the body; it does not identify the product’s regulatory status or prove provider quality. The safer comparison is between visible routes: exact product, authorisation status, accountable prescriber, registered pharmacy, evidence-based testing, transparent costs, monitoring, and follow-up.

What this page is not

  • It is not a recommendation for or against HRT or any hormone product.
  • It is not an assessment of menopause symptoms, hormone levels, suitability, or risk.
  • It is not prescribing, dosing, testing, or monitoring advice.
  • It is not a provider, clinic, doctor, pharmacy, or product ranking.
  • It is not medical, legal, or regulatory advice.
What is a hormone clinic in the UK? How to choose a private hormone clinic in the UK What is a private prescription? What does private prescription cost in the UK mean? What is the Yellow Card scheme?